journal
MENU ▼
Read by QxMD icon Read
search

Applied Health Economics and Health Policy

journal
https://www.readbyqxmd.com/read/29147931/horses-for-courses-moving-india-towards-universal-health-coverage-through-targeted-policy-design
#1
Dayashankar Maurya, Altaf Virani, S Rajasulochana
The debate on how India's health system should move towards universal health coverage was (meant to be) put to rest by the recent National Health Policy 2017. However, the new policy is silent about tackling bottlenecks mentioned in the said policy proposal. It aims to provide universal access to free primary care by strengthening the public system, and to secondary and tertiary care through strategic purchasing from the private sector, to overcome deficiencies in public provisioning in the short run. Yet, in doing so, it ignores critical factors needed to replicate successful models of public healthcare delivery from certain states that it hopes to emulate...
November 16, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/29124677/scale-effects-and-expected-savings-from-consolidation-policies-of-italian-local-healthcare-authorities
#2
Cinzia Di Novi, Dino Rizzi, Michele Zanette
BACKGROUND: Consolidation is often considered by policymakers as a means to reduce service delivery costs and enhance accountability. OBJECTIVE: The aim of this study was to estimate the potential cost savings that may be derived from consolidation of local health authorities (LHAs) with specific reference to the Italian setting. METHODS: For our empirical analysis, we use data relating to the costs of the LHAs as reported in the 2012 LHAs' Income Statements published within the New Health Information System (NSIS) by the Ministry of Health...
November 9, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/29124676/cost-effectiveness-analysis-of-the-gonadotropin-treatments-hp-hmg-and-rfsh-for-assisted-reproductive-technology-in-france-a-markov-model-analysis
#3
Paul Barriere, Géraldine Porcu-Buisson, Samir Hamamah
OBJECTIVES: The objectives of this study were to assess (1) the expected cost of a live birth (LB) after in vitro fertilization with two different gonadotropin treatments [high purified human menopausal gonadotropin (HP-hMG) and recombinant follicle-stimulating hormone (rFSH)] as the single cost variable, and (2) the cost effectiveness of HP-hMG relative to rFSH in the context of the routine practice of assisted reproductive technology (ART) in France. METHODS: A Markov model was developed to simulate the therapeutic management, the in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) courses, and the effects of complications in hypothetical cohorts of 30,000 patients undergoing IVF/ICSI with fresh embryo transfer (up to four attempts) using data from the MERIT and MEGASET clinical trials or from French routine ART practice...
November 9, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/29119475/comparative-cost-effectiveness-analysis-of-three-different-automated-medication-systems-implemented-in-a-danish-hospital-setting
#4
Bettina Wulff Risør, Marianne Lisby, Jan Sørensen
INTRODUCTION: Automated medication systems have been found to reduce errors in the medication process, but little is known about the cost-effectiveness of such systems. The objective of this study was to perform a model-based indirect cost-effectiveness comparison of three different, real-world automated medication systems compared with current standard practice. METHODS: The considered automated medication systems were a patient-specific automated medication system (psAMS), a non-patient-specific automated medication system (npsAMS), and a complex automated medication system (cAMS)...
November 8, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/29086228/enduralife-powered-cardiac-resynchronisation-therapy-defibrillator-devices-for-treating-heart-failure-a-nice-medical-technology-guidance
#5
REVIEW
James Michael Evans, Andrew Cleves, Helen Morgan, Liesl Millar, Grace Carolan-Rees
ENDURALIFE™-powered cardiac resynchronisation therapy defibrillator (CRT-D) devices were the subject of an evaluation by the National Institute for Health and Care Excellence, through its Medical Technologies Evaluation Programme, for the treatment of heart failure. Boston Scientific (manufacturer) submitted a case for the adoption of the technology, claiming that it has a longer battery life resulting in a longer time to CRT-D replacement. Other claimed benefits were fewer complications associated with replacement procedures, fewer hospital admissions, less time spent in hospital and reduced demand on cardiology device implantation rooms...
October 31, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/29081000/association-between-medicare-s-mandatory-hospital-value-based-purchasing-program-and-cost-inefficiency
#6
Germán M Izón, Chelsea A Pardini
BACKGROUND: The Patient Protection and Affordable Care Act instituted pay-for-performance programs, including Hospital Value-Based Purchasing (HVBP), designed to encourage hospital quality and efficiency. OBJECTIVE AND METHOD: While these programs have been evaluated with respect to their implications for care quality and financial viability, this is the first study to assess the relationship between hospitals' cost inefficiency and their participation in the programs...
October 28, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/29047072/involving-members-of-the-public-in-health-economics-research-insights-from-selecting-health-states-for-valuation-to-estimate-quality-adjusted-life-year-qaly-weights
#7
Elizabeth Goodwin, Kate Boddy, Lynn Tatnell, Annie Hawton
Over recent years, public involvement in health research has expanded considerably. However, public involvement in designing and conducting health economics research is seldom reported. Here we describe the development, delivery and assessment of an approach for involving people in a clearly defined piece of health economics research: selecting health states for valuation in estimating quality-adjusted life-years (QALYs). This involvement formed part of a study to develop a condition-specific preference-based measure of health-related quality of life, the Multiple Sclerosis Impact Scale (MSIS-8D), and the work reported here relates to the identification of plausible, or realistic, health states for valuation...
October 19, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/29030726/correction-to-a-scoping-review-of-economic-evaluations-alongside-randomised-controlled-trials-of-home-monitoring-in-chronic-disease-management
#8
Kristian Kidholm, Mie Borch Dahl Kristensen
Table 2, 'Stoddart [19]' row: The cell entry in the 'Mean cost per control patient (SE)' column.
October 13, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/28980217/incremental-cost-effectiveness-of-bedaquiline-for-the-treatment-of-rifampicin-resistant-tuberculosis-in-south-africa-model-based-analysis
#9
Kathryn Schnippel, Cynthia Firnhaber, Francesca Conradie, Norbert Ndjeka, Edina Sinanovic
BACKGROUND: Nearly 20,000 people were diagnosed with multi-drug and rifampicin-resistant tuberculosis (MDR/RR-TB) in South Africa in 2015, yet only one-half of the patients who start treatment are expected to have a successful outcome. There is increasing evidence of the effectiveness and safety of new drug regimens containing bedaquiline for MDR/RR-TB; however, whether they are affordable for high-burden, limited-resource settings is uncertain. OBJECTIVE: Our objective was to determine the incremental cost effectiveness of a bedaquiline-based regimen for MDR/RR-TB treatment in South Africa compared with the standard kanamycin-based regimen...
October 4, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/28933057/healthcare-finance-in-the-kingdom-of-saudi-arabia-a-qualitative-study-of-householders-attitudes
#10
Mohammed Khaled Al-Hanawi, Omar Alsharqi, Saja Almazrou, Kirit Vaidya
BACKGROUND: The public sector healthcare system in Saudi Arabia, essentially financed by oil revenues and 'free at the point of delivery', is coming under increasing strain due to escalating expenditure and an increasingly volatile oil market and is likely to be unsustainable in the medium to long term. OBJECTIVES: This study examines how satisfied the Saudi people are with their public sector healthcare services and assesses their willingness to contribute to financing the system through a national health insurance scheme...
September 20, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/28900901/erratum-to-estimated-healthcare-costs-of-melanoma-in-australia-over-3-years-post-diagnosis
#11
Thomas M Elliott, David C Whiteman, Catherine M Olsen, Louisa G Gordon
The last word in the first paragraph which previously read AU$25 million should read 25 million as this relates to population size.
September 12, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/28871514/a-scoping-review-of-economic-evaluations-alongside-randomised-controlled-trials-of-home-monitoring-in-chronic-disease-management
#12
REVIEW
Kristian Kidholm, Mie Borch Dahl Kristensen
Many countries have considered telemedicine and home monitoring of patients as a solution to the demographic challenges that health-care systems face. However, reviews of economic evaluations of telemedicine have identified methodological problems in many studies as they do not comply with guidelines. The aim of this study was to examine economic evaluations alongside randomised controlled trials of home monitoring in chronic disease management and hereby to explore the resources included in the programme costs, the types of health-care utilisation that change as a result of home monitoring and discuss the value of economic evaluation alongside randomised controlled trials of home monitoring on the basis of the studies identified...
September 4, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/28871512/decision-making-and-priority-setting-the-evolving-path-towards-universal-health-coverage
#13
Francesco Paolucci, Ken Redekop, Ayman Fouda, Gianluca Fiorentini
Health technology assessment (HTA) is widely viewed as an essential component in good universal health coverage (UHC) decision-making in any country. Various HTA tools and metrics have been developed and refined over the years, including systematic literature reviews (Cochrane), economic modelling, and cost-effectiveness ratios and acceptability curves. However, while the cost-effectiveness ratio is faithfully reported in most full economic evaluations, it is viewed by many as an insufficient basis for reimbursement decisions...
September 4, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/28866822/dutch-economic-value-of-radium-223-in-metastatic-castration-resistant-prostate-cancer
#14
Michel L Peters, Claudine de Meijer, Dirk Wyndaele, Walter Noordzij, Annemarie M Leliveld-Kors, Joan van den Bosch, Pieter H van den Berg, Agni Baka, Jennifer G Gaultney
BACKGROUND: The treatment of metastatic castration-resistant prostate cancer has changed with the introduction of radium-223, cabazitaxel, abiraterone and enzalutamide. To assess value for money, their cost effectiveness in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel from the Dutch societal perspective was investigated. METHODS: A cost-effectiveness analysis was conducted using efficacy, symptomatic skeletal-related event and safety data obtained from indirect treatment comparisons...
September 2, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/28856585/a-systematic-review-of-cost-of-illness-studies-of-multimorbidity
#15
REVIEW
Lili Wang, Lei Si, Fiona Cocker, Andrew J Palmer, Kristy Sanderson
OBJECTIVES: The economic burden of multimorbidity is considerable. This review analyzed the methods of cost-of-illness (COI) studies and summarized the economic outcomes of multimorbidity. METHODS: A systematic review (2000-2016) was performed, which was registered with Prospero, reported according to PRISMA, and used a quality checklist adapted for COI studies. The inclusion criteria were peer-reviewed COI studies on multimorbidity, whereas the exclusion criterion was studies focusing on an index disease...
August 30, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/28828741/health-expenditure-and-all-cause-mortality-in-the-galaxy-of-italian-regional-healthcare-systems-a-15-year-panel-data-analysis
#16
Davide Golinelli, Fabrizio Toscano, Andrea Bucci, Jacopo Lenzi, Maria Pia Fantini, Nicola Nante, Gabriele Messina
BACKGROUND: The sustainability of healthcare systems is a topic of major interest. During periods of economic instability, policy makers typically reallocate resources and execute linear cuts in different areas of public spending, including healthcare. OBJECTIVES: The aim of this paper was to examine whether and how per capita public healthcare expenditure (PHE) in the Italian regions was related to the all-cause mortality rate (MR) between 1999 and 2013 and to determine which expenditure item most affected mortality in the short and very short term...
August 21, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/28828573/a-cost-benefit-analysis-of-two-alternative-models-of-maternity-care-in-ireland
#17
Christopher G Fawsitt, Jane Bourke, Aileen Murphy, Brendan McElroy, Jennifer E Lutomski, Rosemary Murphy, Richard A Greene
BACKGROUND: The Irish government has committed to expand midwifery-led care alongside consultant-led care nationally, although very little is known about the potential net benefits of this reconfiguration. OBJECTIVES: To formally compare the costs and benefits of the major models of care in Ireland, with a view to informing priority setting using the contingent valuation technique and cost-benefit analysis. METHODS: A marginal payment scale willingness-to-pay question was adopted from an ex ante perspective...
August 21, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/28822113/economic-evaluation-of-interventions-for-children-with-neurodevelopmental-disorders-opportunities-and-challenges
#18
Ramesh Lamsal, Jennifer D Zwicker
Economic evaluation is a tool used to inform decision makers on the efficiency of comparative healthcare interventions and inform resource allocation decisions. There is a growing need for the use of economic evaluations to assess the value of interventions for children with neurodevelopmental disorders (NDDs), a population that has increasing demands for healthcare services. Unfortunately, few evaluations have been conducted to date, perhaps stemming from challenges in applying existing economic evaluation methodologies in this heterogeneous population...
August 18, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/28822106/multiple-criteria-decision-analysis-in-health-technology-assessment-for-drugs-just-another-illusion
#19
EDITORIAL
Livio Garattini, Anna Padula
No abstract text is available yet for this article.
August 18, 2017: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/28578497/authors-reply-to-luft-measuring-the-volume-outcome-relation-for-complex-hospital-surgery
#20
LETTER
Vivian Ho, Woohyeon Kim, Stephen Wolff
No abstract text is available yet for this article.
August 2017: Applied Health Economics and Health Policy
journal
journal
40237
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"